αž αž·αžšαž‰αŸ’αž‰αžœαžαŸ’αžαž»
αž αž·αžšαž‰αŸ’αž‰αžœαžαŸ’αžαž»
αž‘αžΈαž•αŸ’αžŸαžΆαžš
Roche Holding AG
381.40Β CHF
27 αž€αž»αž˜αŸ’αž—αŸˆ, 10:05:00 PM αž˜αŸ‰αŸ„αž„β€‹αžŸαž€αž› +1 · CHF · SWX · αžŸαŸαž…αž€αŸ’αžŠαžΈαž”αŸ’αžšαž€αžΆαžŸαž˜αž·αž“αž‘αž‘αž½αž›αžαž»αžŸαžαŸ’αžšαžΌαžœ
αž—αžΆαž‚β€‹αž αŸŠαž»αž“αž˜αžΌαž›αž”αžαŸ’αžšαžŠαŸ‚αž›αž”αžΆαž“αž…αž»αŸ‡αž”αž‰αŸ’αž‡αžΈαž“αŸ… CHαž˜αžΆαž“αž‘αžΈαžŸαŸ’αž“αžΆαž€αŸ‹αž€αžΆαžšαž€αžŽαŸ’αžŠαžΆαž›αž“αŸ… CH
αž”αž·αž‘αž–αžΈαž˜αž»αž“
369.80Β CHF
αž…αž“αŸ’αž›αŸ„αŸ‡αžαŸ’αž„αŸƒαž“αŸαŸ‡
370.40Β CHF - 381.40Β CHF
αž…αž“αŸ’αž›αŸ„αŸ‡αž˜αž½αž™αž†αŸ’αž“αžΆαŸ†αž…αž»αž„αž€αŸ’αžšαŸ„αž™
244.00Β CHF - 383.00Β CHF
αžŠαžΎαž˜β€‹αž‘αž»αž“β€‹αž‘αžΈαž•αŸ’αžŸαžΆαžš
333.71Β αž”αŸŠαžΈαž›αžΆαž“ CHF
αž‘αŸ†αž αŸ†αž‡αž½αž‰αžŠαžΌαžšαž˜αž’αŸ’αž™αž˜
24.08Β αž–αžΆαž“αŸ‹
αž’αž“αž»αž”αžΆαž P/E
23.78
αž‘αž·αž“αŸ’αž“αž•αž›β€‹αž—αžΆαž‚αž›αžΆαž—
2.57%
αž–αŸαžαŸŒαž˜αžΆαž“αž‘αžΈαž•αŸ’αžŸαžΆαžš
.DJI
1.05%
.DJI
1.05%
αž αž·αžšαž‰αŸ’αž‰αžœαžαŸ’αžαž»
αžšαž”αžΆαž™αž€αžΆαžšαžŽαŸαž”αŸ’αžšαžΆαž€αŸ‹αž…αŸ†αžŽαžΌαž›
αž…αŸ†αžŽαžΌαž›
αž…αŸ†αžŽαžΌαž›αžŸαž»αž‘αŸ’αž’
(CHF)αž’αŸ’αž“αžΌ 2025αž€αžΆαžšαž•αŸ’αž›αžΆαžŸαŸ‹αž”αŸ’αžŠαžΌαžšαžαžΆαž˜β€‹αž†αŸ’αž“αžΆαŸ†
αž…αŸ†αžŽαžΌαž›
15.75Β αž”αŸŠαžΈαž›αžΆαž“-0.42%
αž…αŸ†αžŽαžΆαž™αž”αŸ’αžšαžαž·αž”αžαŸ’αžαž·αž€αžΆαžš
6.82Β αž”αŸŠαžΈαž›αžΆαž“-6.61%
αž…αŸ†αžŽαžΌαž›αžŸαž»αž‘αŸ’αž’
2.74Β αž”αŸŠαžΈαž›αžΆαž“170.93%
αž”αŸ’αžšαžΆαž€αŸ‹αž…αŸ†αžŽαŸαž‰αžŸαž»αž‘αŸ’αž’
17.36172.10%
β€‹αž…αŸ†αžŽαžΌαž›αžŸαž»αž‘αŸ’αž’β€‹αž€αŸ’αž“αž»αž„αž˜αž½αž™αž—αžΆαž‚αž αŸŠαž»αž“
β€”β€”
αž…αŸ†αžŽαžΌαž›αžŸαž»αž‘αŸ’αž’αž˜αž»αž“αž€αžΆαžšαž”αŸ’αžšαžΆαž€αŸ‹ αž–αž“αŸ’αž’ αž€αžΆαžšαžšαŸ†αž›αžŸαŸ‹ αž“αž·αž„αž€αžΆαžšαž€αžΆαžαŸ‹αžšαŸ†αž›αžŸαŸ‹
5.50Β αž”αŸŠαžΈαž›αžΆαž“5.93%
αž’αžαŸ’αžšαžΆαž–αž“αŸ’αž’αžŠαŸ‚αž›αž˜αžΆαž“αž”αŸ’αžšαžŸαž·αž‘αŸ’αž’αž—αžΆαž–
19.20%β€”
αž‘αŸ’αžšαž–αŸ’αž™αžŸαžšαž»αž”
αž€αžΆαžšαž‘αž‘αž½αž›αžαž»αžŸαžαŸ’αžšαžΌαžœαžŸαžšαž»αž”
(CHF)αž’αŸ’αž“αžΌ 2025αž€αžΆαžšαž•αŸ’αž›αžΆαžŸαŸ‹αž”αŸ’αžŠαžΌαžšαžαžΆαž˜β€‹αž†αŸ’αž“αžΆαŸ†
αžŸαžΆαž…αŸ‹αž”αŸ’αžšαžΆαž€αŸ‹ αž“αž·αž„αž€αžΆαžšαžœαž·αž“αž·αž™αŸ„αž‚αžšαž™αŸˆαž–αŸαž›αžαŸ’αž›αžΈ
15.49Β αž”αŸŠαžΈαž›αžΆαž“-10.66%
αž‘αŸ’αžšαž–αŸ’αž™αžŸαžšαž»αž”
100.70Β αž”αŸŠαžΈαž›αžΆαž“-1.08%
αž€αžΆαžšαž‘αž‘αž½αž›αžαž»αžŸαžαŸ’αžšαžΌαžœαžŸαžšαž»αž”
62.82Β αž”αŸŠαžΈαž›αžΆαž“-4.29%
αž˜αžΌαž›β€‹αž’αž“αžŸαžšαž»αž”
37.88Β αž”αŸŠαžΈαž›αžΆαž“β€”
αž—αžΆαž‚αž αŸŠαž»αž“β€‹αž˜αž·αž“β€‹αž‘αžΆαž“αŸ‹αž”αžΆαž“αž”αž„αŸ‹
795.62Β αž›αžΆαž“β€”
αžαž˜αŸ’αž›αŸƒαž’αŸ€αž”αž“αžΉαž„αžŸαŸ€αžœαž—αŸ…
8.70β€”
αž•αž›αž…αŸ†αžŽαŸαž‰αž›αžΎαž‘αŸ’αžšαž–αŸ’αž™
11.73%β€”
αž•αž›αž…αŸ†αžŽαŸαž‰αž›αžΎαžŠαžΎαž˜αž‘αž»αž“
16.62%β€”
αž€αžΆαžšαž”αŸ’αžšαŸ‚αž”αŸ’αžšαž½αž›β€‹αžŸαžΆαž…αŸ‹αž”αŸ’αžšαžΆαž€αŸ‹αžŸαž»αž‘αŸ’αž’
(CHF)αž’αŸ’αž“αžΌ 2025αž€αžΆαžšαž•αŸ’αž›αžΆαžŸαŸ‹αž”αŸ’αžŠαžΌαžšαžαžΆαž˜β€‹αž†αŸ’αž“αžΆαŸ†
αž…αŸ†αžŽαžΌαž›αžŸαž»αž‘αŸ’αž’
2.74Β αž”αŸŠαžΈαž›αžΆαž“170.93%
αžŸαžΆαž…αŸ‹αž”αŸ’αžšαžΆαž€αŸ‹αž–αžΈαž”αŸ’αžšαžαž·αž”αžαŸ’αžαž·αž€αžΆαžš
5.88Β αž”αŸŠαžΈαž›αžΆαž“-3.51%
αžŸαžΆαž…αŸ‹αž”αŸ’αžšαžΆαž€αŸ‹αž–αžΈαž€αžΆαžšαžœαž·αž“αž·αž™αŸ„αž‚
-5.19Β αž”αŸŠαžΈαž›αžΆαž“-21.67%
αžŸαžΆαž…αŸ‹αž”αŸ’αžšαžΆαž€αŸ‹αž–αžΈαž αž·αžšαž‰αŸ’αž‰β€‹αž”αŸ’αž”αž‘αžΆαž“
-1.62Β αž”αŸŠαžΈαž›αžΆαž“-136.86%
αž€αžΆαžšαž”αŸ’αžšαŸ‚αž”αŸ’αžšαž½αž›β€‹αžŸαžΆαž…αŸ‹αž”αŸ’αžšαžΆαž€αŸ‹αžŸαž»αž‘αŸ’αž’
-986.00Β αž›αžΆαž“-191.68%
αž›αŸ†αž αžΌαžšαžŸαžΆαž…αŸ‹αž”αŸ’αžšαžΆαž€αŸ‹αž‘αŸ†αž“αŸαžš
2.53Β αž”αŸŠαžΈαž›αžΆαž“15.49%
αž’αŸ†αž–αžΈ
F. Hoffmann-La Roche AG, commonly known as Roche, is a Swiss multinational holding healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. Its holding company, Roche Holding AG, has shares listed on the SIX Swiss Exchange. The company headquarters are located in Basel. Roche is the fifth-largest pharmaceutical company in the world by revenue and the leading provider of cancer treatments globally. In 2023, the company’s seat in Forbes Global 2000 was 76. The company owns the American biotechnology company Genentech, which is a wholly owned independent subsidiary, and the Japanese biotechnology company Chugai Pharmaceuticals, as well as the United States–based companies Ventana and Foundation Medicine. Roche's revenues during fiscal year 2020, were 58.32 billion Swiss francs. Descendants of the founding Hoffmann and Oeri families own slightly over half of the bearer shares with voting rights, with Swiss pharma firm Novartis owning a further third of its shares until 2021. F. Hoffmann-La Roche is a full member of the European Federation of Pharmaceutical Industries and Associations. Wikipedia
αž”αžΆαž“αž”αž„αŸ’αž€αžΎαžαž‘αžΎαž„
1 αžαž»αž›αžΆ 1896
αž€αžΆαžšαž·αž™αžΆαž›αŸαž™β€‹αž€αžŽαŸ’αžŠαžΆαž›
αžαŸ†αž”αž“αŸ‹β€‹αž”αžŽαŸ’αžŠαžΆαž‰
αž”αž»αž‚αŸ’αž‚αž›αž·αž€
112,774
αžŸαŸ’αžœαŸ‚αž„αžšαž€β€‹αž…αŸ’αžšαžΎαž“αž‘αŸ€αž
αž’αŸ’αž“αž€αž’αžΆαž…αž…αžΆαž”αŸ‹αž’αžΆαžšαž˜αŸ’αž˜αžŽαŸαž›αžΎ
αž”αž‰αŸ’αž‡αžΈαž“αŸαŸ‡αžαŸ’αžšαžΌαžœαž”αžΆαž“αž”αž„αŸ’αž€αžΎαžαž‘αžΎαž„αž–αžΈαž€αžΆαžšαžŸαŸ’αžœαŸ‚αž„αžšαž€αžαŸ’αž˜αžΈαŸ— αž˜αžΌαž›αž”αžαŸ’αžšαžŠαŸ‚αž›αž”αžΆαž“αžαžΆαž˜αžŠαžΆαž“ αž“αž·αž„αžŸαž€αž˜αŸ’αž˜αž—αžΆαž–αž•αŸ’αžŸαŸαž„αž‘αŸ€αžαŸ” αžŸαŸ’αžœαŸ‚αž„αž™αž›αŸ‹αž”αž“αŸ’αžαŸ‚αž˜

αž‘αž·αž“αŸ’αž“αž“αŸαž™ αž“αž·αž„αž–αŸαžαŸŒαž˜αžΆαž“αž‘αžΆαŸ†αž„αž’αžŸαŸ‹αžαŸ’αžšαžΌαžœαž”αžΆαž“αž•αŸ’αžαž›αŸ‹αž‡αžΌαž“ β€œαžŠαžΌαž…αžŠαŸ‚αž›αž˜αžΆαž“β€ αžŸαž˜αŸ’αžšαžΆαž”αŸ‹αžαŸ‚αž‚αŸ„αž›αž”αŸ†αžŽαž„αž–αŸαžαŸŒαž˜αžΆαž“αž•αŸ’αž‘αžΆαž›αŸ‹αžαŸ’αž›αž½αž“αž”αŸ‰αž»αžŽαŸ’αžŽαŸ„αŸ‡ αž αžΎαž™αž˜αž·αž“αž˜αžΆαž“αž‚αŸ„αž›αž”αŸ†αžŽαž„αž•αŸ’αžŠαž›αŸ‹β€‹αž‡αžΆαžŠαŸ†αž”αžΌαž“αŸ’αž˜αžΆαž“αž•αŸ’αž“αŸ‚αž€αž αž·αžšαž‰αŸ’αž‰αžœαžαŸ’αžαž» αž¬αž€αŸαžŸαž˜αŸ’αžšαžΆαž”αŸ‹αž‚αŸ„αž›αž”αŸ†αžŽαž„αž–αžΆαžŽαž·αž‡αŸ’αž‡αž€αž˜αŸ’αž˜αž¬αž€αžΆαžšαžœαž·αž“αž·αž™αŸ„αž‚ αž–αž“αŸ’αž’ αž…αŸ’αž”αžΆαž”αŸ‹ αž‚αžŽαž“αŸαž™αŸ’αž™ αž¬αžŠαŸ†αž”αžΌαž“αŸ’αž˜αžΆαž“αž•αŸ’αžŸαŸαž„αž‘αŸ€αžαž‘αžΎαž™αŸ” Google αž˜αž·αž“αž˜αŸ‚αž“αž‡αžΆαž‘αžΈαž”αŸ’αžšαžΉαž€αŸ’αžŸαžΆαž•αŸ’αž“αŸ‚αž€αžœαž·αž“αž·αž™αŸ„αž‚ αž¬αž‘αžΈαž”αŸ’αžšαžΉαž€αŸ’αžŸαžΆαž•αŸ’αž“αŸ‚αž€αž αž·αžšαž‰αŸ’αž‰αžœαžαŸ’αžαž»αž‘αŸ αž“αž·αž„αž˜αž·αž“αž”αž‰αŸ’αž…αŸαž‰αž‘αžŸαŸ’αžŸαž“αŸˆ αž€αžΆαžšαžŽαŸ‚αž“αžΆαŸ† αž¬αž‚αŸ†αž“αž·αžαž™αŸ„αž”αž›αŸ‹αž–αžΆαž€αŸ‹αž–αŸαž“αŸ’αž’αž“αžΉαž„αž€αŸ’αžšαž»αž˜αž αŸŠαž»αž“αžŽαžΆαž˜αž½αž™αžŠαŸ‚αž›αž˜αžΆαž“αž€αŸ’αž“αž»αž„αž”αž‰αŸ’αž‡αžΈαž“αŸαŸ‡ αž¬αž˜αžΌαž›αž”αžαŸ’αžšαžŽαžΆαž˜αž½αž™αžŠαŸ‚αž›αž…αŸαž‰αžŠαŸ„αž™αž€αŸ’αžšαž»αž˜αž αŸŠαž»αž“αž‘αžΆαŸ†αž„αž“αŸ„αŸ‡αžŠαŸ‚αžšαŸ” αžŸαžΌαž˜αž–αž·αž‚αŸ’αžšαŸ„αŸ‡αž‡αžΆαž˜αž½αž™αžˆαŸ’αž˜αž½αž‰αž€αžŽαŸ’αžαžΆαž› αž¬αžαŸ†αžŽαžΆαž„αž•αŸ’αž“αŸ‚αž€αž αž·αžšαž‰αŸ’αž‰αžœαžαŸ’αžαž»αžšαž”αžŸαŸ‹αž’αŸ’αž“αž€ αžŠαžΎαž˜αŸ’αž”αžΈαž•αŸ’αž‘αŸ€αž„αž•αŸ’αž‘αžΆαžαŸ‹αžαž˜αŸ’αž›αŸƒαž˜αž»αž“αž“αžΉαž„αž”αŸ’αžšαžαž·αž”αžαŸ’αžαž·αž€αžΆαžšαž‡αž½αž‰αžŠαžΌαžšαžŽαžΆαž˜αž½αž™αŸ” αžŸαŸ’αžœαŸ‚αž„αž™αž›αŸ‹αž”αž“αŸ’αžαŸ‚αž˜
αž€αŸαž˜αžΆαž“β€‹αž’αŸ’αž“αž€β€‹αžŸαŸ’αžœαŸ‚αž„αžšαž€β€‹αžŠαŸ‚αžš
αžŸαŸ’αžœαŸ‚αž„αžšαž€
αžŸαž˜αŸ’αž’αžΆαžβ€‹αž€αžΆαžšβ€‹αžŸαŸ’αžœαŸ‚αž„αžšαž€
αž”αž·αž‘β€‹αž€αžΆαžšβ€‹αžŸαŸ’αžœαŸ‚αž„αžšαž€
αž€αž˜αŸ’αž˜αžœαž·αž’αžΈ Google
αž˜αŸ‰αžΊαž“αž»αž™αžŠαžΎαž˜